Zolpidem Postmarketing Study in Adolescent Patients With Insomnia
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
12 Years to 18 Years (Child, Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
patients diagnosed as having nonorganic insomnia of nonorganic sleep disorder in ICD10
patients whose age at the time of obtaining consent is 12 years or over and 18 years or below
patients with schizophrenia or manic-depressive illness
patients with insomnia caused by physical diseases
patients having a history of hypersensitivity to zolpidem
patients with attention-deficit hyperactivity disorder